)
Edge31 Oct 2025
Rolls-Royce: Full Thrust Ahead
From century-old crafted perfection to pandemic shock and reset, Rolls-Royce's story is shaped by heritage, turbulence, and a disciplined climb back.
Cytek Biosciences (CTKB) investor relations material
Cytek Biosciences Morgan Stanley 23rd Annual Global Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Morgan Stanley 23rd Annual Global Healthcare Conference summary10 Sep, 2025
Key accomplishments and market environment
Navigated unexpected export controls, tariffs, and funding reductions with minimal impact due to prior region-for-region manufacturing preparations.
Achieved 3% year-over-year unit growth in core Full Spectrum Profiling (FSP) instruments despite a challenging market.
Full spectral profiling technology has become the industry standard, with competitors following suit.
Maintained leadership in the flow cytometry market, benefiting from a growing installed base and technology adoption.
Managed through capital expenditure headwinds, with replacement cycles and incentives driving future demand.
Market opportunity and adoption trends
Flow cytometry total addressable market (TAM) estimated at $16 billion, with current penetration still under 10% for FSP instruments.
Market growth slowed due to over-investment during the pandemic and reduced funding for startups, but long-term replacement needs remain strong.
U.S. academic/government market has stabilized after funding fears, while EMEA faces ongoing budget constraints due to increased defense spending.
Asia-Pacific, especially China, shows robust growth, supported by government funding and increasing market share.
Product innovation and portfolio updates
Launched Aurora Evo, tailored for pharma with enhanced automation, small particle support, and harmonization features.
Aurora Evo positioned at a premium to Aurora, with pricing similar to the cell sorter depending on configuration.
Cell sorter and Northern Lights continue solid performance; Ming Yan Micro sees strong uptake but limited revenue impact due to low ASP.
FSP penetration: Key drivers for future growth?
Reagent growth: Strategies to capture market share?
Aurora EVO: Impact on instrument mix and ASPs?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Cytek Biosciences earnings date
Q3 20255 Nov, 2025
Next Cytek Biosciences earnings date
Q3 20255 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Cytek Biosciences Inc. is a biotechnology company specializing in cell analysis solutions. The company develops and manufactures flow cytometry instruments, reagents, and software used in biomedical research and clinical diagnostics. Cytek’s technologies enable the study of cell characteristics, functions, and biomarkers, supporting research in immunology, oncology, and other areas of life sciences. The company serves academic institutions, pharmaceutical companies, and clinical laboratories, providing tools for advanced cellular analysis and discovery. The company is headquartered in Fremont, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage